James Jones's Net Worth
-$71.8 Thousand
Who is James Jones?
James Jones does not have any significant net worth to report based on the numbers we have. This is based on reported shares in CUMBERLAND PHARMACEUTICALS INC.
SEC CIK
James Jones's CIK is 0001490829
Past Insider Trading and Trends
2022 was James Jones's most active year for acquiring shares with 173 total transactions. James Jones's most active month to acquire stocks was the month of July. 2010 saw James Jones paying a total of $20,702.70 for 3,700 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CUMBERLAND PHARMACEUTICALS INC (CPIX) Snapshot price: $1.41
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +3.91% | 1.43K |
$1.28 | $1,827.14 | 37.87K |
Scheduled
|
Oct 1 - Oct 31
| ||
Form 4
| +2.37% | 822 |
$1.42 | $1,163.13 | 35.55K |
Scheduled
|
Aug 1 - Aug 30
| ||
Form 4
| +2.57% | 870 |
$1.49 | $1,295.15 | 34.73K |
Scheduled
|
Jul 1 - Jul 31
| ||
Form 4
| +1.36% | 454 |
$1.52 | $691.38 | 33.86K |
Scheduled
|
Jun 13 - Jun 28
| ||
Form 4
| +3.09% | 1K |
$1.71 | $1,710.00 | 33.41K |
Mar 25
| |||
Form 4
| +3.76% | 1.17K |
$1.77 | $2,076.56 | 32.41K |
Scheduled
|
Dec 1 - Dec 21
| ||
Form 4
| +3.14% | 952 |
$1.83 | $1,741.38 | 31.23K |
Scheduled
|
Nov 1 - Nov 30
| ||
Form 4
| +3.94% | 1.15K |
$2.01 | $2,302.35 | 30.28K |
Scheduled
|
Oct 2 - Oct 31
| ||
Form 4
| +3.90% | 1.09K |
$1.92 | $2,097.01 | 29.13K |
Sep 5 - Sep 29
| |||
Form 4
| +2.74% | 747 |
$1.69 | $1,261.03 | 28.04K |
Aug 16 - Aug 31
| |||
Form 4
| +3.80% | 1K |
$1.97 | $1,970.00 | 27.29K |
Mar 24
| |||
Form 4
| +2.60% | 667 |
$2.23 | $1,486.85 | 26.29K |
Scheduled
|
Dec 1 - Dec 21
| ||
Form 4
| +2.61% | 651 |
$2.37 | $1,543.18 | 25.63K |
Scheduled
|
Nov 1 - Nov 30
| ||
Form 4
| +3.20% | 775 |
$2.49 | $1,933.47 | 24.98K |
Scheduled
|
Sep 27 - Oct 31
| ||
Form 4
| +4.20% | 976 |
$2.44 | $2,376.72 | 24.23K |
Scheduled
|
Aug 16 - Sep 27
| ||
Form 4
| +4.76% | 1.06K |
$2.31 | $2,445.99 | 23.25K |
Scheduled
|
Jul 1 - Aug 15
| ||
Form 4
| +3.72% | 797 |
$2.04 | $1,627.57 | 22.2K |
Scheduled
|
Jun 1 - Jun 30
| ||
Form 4
| +3.47% | 718 |
$2.30 | $1,649.62 | 21.4K |
Scheduled
|
May 2 - May 31
| ||
Form 4
| +1.56% | 318 |
$2.61 | $830.30 | 20.68K |
Scheduled
|
Apr 14 - Apr 29
| ||
Form 4
| +5.16% | 1K |
$2.59 | $2,590.00 | 20.36K |
Mar 16
| |||
Form 4
| +2.23% | 423 |
$4.56 | $1,929.65 | 19.36K |
Scheduled
|
Dec 1 - Dec 20
| ||
Form 4
| +4.88% | 882 |
$2.72 | $2,401.56 | 18.94K |
Scheduled
|
Nov 1 - Nov 30
| ||
Form 4
| +5.13% | 882 |
$2.72 | $2,399.46 | 18.06K |
Scheduled
|
Oct 1 - Oct 29
| ||
Form 4
| +5.41% | 882 |
$2.83 | $2,495.22 | 17.18K |
Scheduled
|
Sep 1 - Sep 30
| ||
Form 4
| +5.72% | 882 |
$2.98 | $2,626.68 | 16.3K |
Scheduled
|
Aug 2 - Aug 31
| ||
Form 4
| +4.86% | 714 |
$3.32 | $2,367.54 | 15.41K |
Scheduled
|
Jul 8 - Jul 30
| ||
Form 4
| +7.30% | 1K |
$3.22 | $3,220.00 | 14.7K |
Mar 17
| |||
Form 4
| +7.87% | 1K |
$3.56 | $3,560.00 | 13.7K |
Mar 23
| |||
Form 4
| +8.55% | 1K |
$5.98 | $5,980.00 | 12.7K |
Mar 22
| |||
Form 4
| +9.35% | 1K |
$6.70 | $6,700.00 | 11.7K |
Mar 23
| |||
Form 4
| +10.31% | 1K |
$6.45 | $6,450.00 | 10.7K |
Apr 7
| |||
Form 4
| +11.49% | 1K |
$4.34 | $4,340.00 | 9.7K |
Apr 6
| |||
Form 4
| +14.29% | 1K |
$6.86 | $6,860.00 | 8K |
Mar 27
| |||
Form 4
| +16.67% | 1K |
$4.58 | $4,580.00 | 7K |
Mar 21
| |||
Form 4
| +20.00% | 1K |
$4.78 | $4,780.00 | 6K |
Mar 26
| |||
Form 4
| +25.00% | 1K |
$7.72 | $7,720.00 | 5K |
Mar 16
| |||
Form 4
| +33.33% | 1K |
—
|
—
| 4K |
Mar 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
∞
| 3K |
$6.90 | $20,702.70 | 3K |
May 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |